LIFESAVING After being on the Be the Match registry for eight months, Lacey Jones donated stem cells to a 75-year-old woman battling myeloid leukemia.
A Kokomo teacher has spent part of her summer possibly saving the life of a 75-year-old woman.
Late last month, Lacey Jones, a veterinary careers instructor at the Kokomo Area Career Center, traveled to the Hoxworth Blood Center at the University of Cincinnati to donate stem cells to a woman she was genetically matched with who was battling myeloid leukemia. Now, all Jones hopes is that her stem cells were enough.
I really want nothing more than to hear that she is in remission. That was the emotional part of the process. Once it was all over, I just went to my hotel room, and I could not help but to just kind of cry and cry and cry and pray and hope because you want nothing more than for your cells to work for the patient, Jones said.
But the opportunity to help someone was a chance that some dont ever get. Jones registered as a donor through Be the Match, which operates the national bone marrow registry, late last year after the story of her friends daughter, who was diagnosed with infant leukemia, inspired her to want to help someone.
According to Be the Match, only one of 430 people who register as a donor is selected as a match, and some of those who are selected wait years before theyre matched. For Jones, she became a genetic match for someone in just eight months.
At the end of May, she received a call from Be the Match, letting her know that there was a woman who had been diagnosed with myeloid leukemia, and Jones was a secondary match for her. Jones was told that there was someone who was the primary match who matched just a little better, but in the chance that that donor fell through, Jones would be at the plate.
I just kind of waited around, didnt really think anything of it, and then they called me at the beginning of June. She explained that the original person who matched ended up not being who they really needed, and of course with HIPPA and all that they cant really tell you any of that information as to why, Jones said.
As far as the patient, all Jones was told was that it was a 75-year-old woman who was battling myeloid leukemia somewhere in the world. Jones was asked if shed be available to donate during certain dates, but at that point, there were no details as to where she would be donating or exactly when. What Jones did know, though, was that she would do it.
The process then became a whirlwind of scheduling, logistics, and injections. She went to Indianapolis for lab work to ensure she was healthy enough to donate. Then, for a week leading up to her donation, she was required to take injections of a drug called filgrastim to increase the number of white blood cells in her bloodstream so they could be collected more easily.
Theyre actual injections that are given to people who have cancer to increase the white blood cell count, but theyre given to donors because it increases your bone marrow production. Then what happens is your body naturally expels the extra bone marrow into the bloodstream, she said.
Jones was a bit hesitant because shed never given herself injections before, and she was warned of the side effects that could occur. The most common side effect of filgrastim, she said, was soreness due to the overproduction of bone marrow.
They explained some of the side effects of the filgrastim, and that makes you feel a little intimidated. But because of my passion and my empathy for the patient and hearing about there not being donors and just knowing that I could potentially help save her life, it overruled any type of fear I had, she said.
At the end of June, Jones traveled to Hoxworth Blood Center at the University of Cincinnati to begin the donation.
Now, more than ever, the world needs trustworthy reportingbut good journalism isnt free.Please support us by making a contribution.
There are two donation methods, either marrow or peripheral blood stem cells. The marrow donation is a surgical procedure done under anesthesia. Doctors use needles to retrieve liquid marrow from both sides of the back of a patients pelvic bone. The hospital stay is usually from early morning to late afternoon, according to Be the Match, while some donors are kept overnight for observation.
The peripheral stem cell donation, on the other hand, is a non-surgical procedure that takes place at a blood center or outpatient hospital. Blood is removed through a needle in one arm and passed through a machine that collects only the blood-forming cells and returns the blood through a needle in the donors other arm.
As soon as Jones got to the blood center, nurses took a blood sample to see where her white blood cell count was. A normal count, she said, was between four and 10. Hers was at 42. Because the filgrastim injections were so effective for Jones, she was able to do the peripheral stem cell method.
So began a five-hour process of Jones sitting very still while a machine filtered out blood-forming cells from her left arm and put the blood back in her right arm. The nurses took her blood pressure every 15 minutes to ensure she wasnt having any kind of reaction, and the staff knew down to the minute when her donation would be complete, she said, and had the transfer staff ready.
At the end of the donation, Jones said it was like a movie when the person came in to take her stem cells that would be delivered to the patient.
They actually had somebody come up with the cooler because they flew my sample to the patient. Its almost like a movie. You watch someone come through the big steel door with the cooler and watch them package your sample, she said.
And while she didnt know where the sample was going, she was told the recipient was nowhere close to where they were.
When the process was over, Jones was thankful. She said the nurses told her it was a textbook donation, and the only side effect Jones experienced from the injections was mild soreness.
Three months after the donation, the recipient will have the option to find out who her donor was and to contact Jones if she chooses.
Jones said shed love to one day hear from the recipient.
I want nothing more than to one day get that phone call that says, OK, the person you donated to wants to get in contact with you. I dont know what Ill do. Ill probably cry again, she said.
Jones will remain on the Be the Match registry, and in the event she ever receives a call that shes a match again, she will be ready to go, she said.
To join the bone marrow donor registry, visit join.bethematch.org. The process requires a cheek swab, which can be done with a kit thats mailed to potential donors. Afterward, the person will be added to the registry and have the chance to get matched.
Be the Match encourages those who are contacted to donate to go forward with the donation as theyre the patients best genetic match from the entire registry.
- Cellino is using AI and machine learning to scale production of stem cell therapies - TechCrunch - September 22nd, 2021
- Capping Medicare Part B payments will limit outpatient access to CAR-T - STAT - September 22nd, 2021
- Treating Patients with High-Risk Myelodysplastic Syndrome - Targeted Oncology - September 22nd, 2021
- FDA Issues Draft Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals | FDA - FDA.gov - September 22nd, 2021
- CD19 As a Targeted Agent in CAR T Cell Therapy for R/R DLBCL - Targeted Oncology - September 22nd, 2021
- Stem Rx Bioscience Solutions successfully use cell-based therapy for age-related macular degeneration and restoration of vision - Financial Express - September 22nd, 2021
- Repeated injury to the epithelial tissue of airways causes "biological aging" of stem cells - News-Medical.net - September 22nd, 2021
- Revival of the cell and gene therapy field opens new avenues for repairing the Parkinsonian brain - News-Medical.Net - September 22nd, 2021
- Scientists Awarded The Albany Prize, America's Most Distinguished Prize in Medicine, for Research Leading to Covid-19 Vaccines - Albany Medical Center - September 22nd, 2021
- Why I Believe It Is Wrong To Take The COVID Vaccine - And Response - The Chattanoogan - September 22nd, 2021
- How can fertility counseling be implemented for every newly diagnosed pediatric patient facing gonadotoxic ... - Physician's Weekly - September 20th, 2021
- Mantle Cell Lymphoma Treatment in the Era of COVID-19 - Curetoday.com - September 20th, 2021
- Calloway County Health Department announces 23 new cases of COVID-19 - Murray Ledger and Times - September 20th, 2021
- Effects of Leukemia on Your Body - Healthline - September 20th, 2021
- DCGI approves stem cell-based therapy trial for COVID-19 pneumonia treatment - BSI bureau - September 17th, 2021
- Dr. Anderson on the Challenges Faced With CAR T-Cell Therapy in Myeloma - OncLive - September 17th, 2021
- Treatment Methods: Transplant Eligibility in R/R DLBCL and CAR T Cell Therapy - Targeted Oncology - September 17th, 2021
- Insights into the cellular and molecular changes in male infertility - EurekAlert - September 17th, 2021
- Loss of Vision Caused by AMD: Cell-Based Therapy Can Help Restore Your Eyesight - TheHealthSite - September 17th, 2021
- The Promise of Regenerative Medicine to Treat Chronic Pain - Newswise - September 17th, 2021
- Researchers build the ovarian environment using mouse stem cells - News-Medical.net - September 17th, 2021
- Molecular and Cellular Changes in the Testicular Tissue of Infertile Men Revealed - Technology Networks - September 17th, 2021
- Magenta Therapeutics Announces IND Clearance for MGTA-117 Targeted Conditioning Clinical Trial - Yahoo Finance - September 17th, 2021
- Indolent lymphoma: Symptoms, outlook, treatment, and more - Medical News Today - September 17th, 2021
- Dr. Shah on Unmet Needs With CAR T-Cell Therapy in Multiple Myeloma - OncLive - September 17th, 2021
- Researchers focus on improving biomaterials used for bone and tissue repair - News-Medical.net - September 17th, 2021
- Dr. Kahl on Patient Selection for Intensive Vs Non-Intensive Treatment in MCL - OncLive - September 17th, 2021
- Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and ... - The Bakersfield Californian - September 14th, 2021
- Meet the Finnish team using stem cells to cure blindness - Sifted - September 14th, 2021
- Why you should feel optimistic about the future of healthcare - Say - Say Communications - September 14th, 2021
- Treating Hearing Loss: The Hunt for Drugs That Promote Hair Cell Regeneration - Technology Networks - September 14th, 2021
- Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and... - September 14th, 2021
- Celebrating the End of Cancer Treatment - Curetoday.com - September 14th, 2021
- BlueCross Will Cover Costs for COVID-19 Booster - Business Wire - September 14th, 2021
- UAB opening vaccination sites in Hoover and Ensley - UAB News - September 12th, 2021
- CardiAMP Cell Therapy Heart Failure Trial to be Featured in Two Presentations at Heart Failure Society of America Annual Meeting 2021 - Yahoo Finance - September 10th, 2021
- A Knee or Hip Replacement Without Surgery? Its on the Horizon - The Wall Street Journal - September 10th, 2021
- Jerry Nelson: Stem cell treatment can be alternative to joint replacement - Watertown Public Opinion - September 10th, 2021
- Graft Vs Host Prophylaxis With Posttransplant Cyclophosphamide Not Associated With Increased Infection Risk - Hematology Advisor - September 10th, 2021
- Carolina Researchers Lead CZI Collaborative on Childhood Diseases | Newsroom - UNC Health and UNC School of Medicine - September 10th, 2021
- A New Opportunity To Receive Sight - mvprogress - September 8th, 2021
- Japan: A case study of national readiness for regenerative medicine - Open Access Government - September 8th, 2021
- Merger Proposals Blocked By Cell Therapies Developer - Labmate Online - September 8th, 2021
- Using Predictive, Data Analytics to Expand Knowledge of Alzheimer's - HealthITAnalytics.com - September 8th, 2021
- Research on preterm brain injury treatment recognised - Medicine, Nursing and Health Sciences - Monash University - September 8th, 2021
- Roche bets $300M on Adaptimmune tech for off-the-shelf cell therapies for cancer - MedCity News - September 8th, 2021
- Desperate family have just three weeks to find stem cell donor for their girl - Express - September 8th, 2021
- Ivy Tech nursing student among 234 who want religious exemption to vaccine mandate - The Indianapolis Star - September 8th, 2021
- Convection Improves Survival and Insulin Secretion of Beta Cell Implants - Genetic Engineering & Biotechnology News - September 8th, 2021
- Bone Therapeutics reports half year 2021 results - GlobeNewswire - September 8th, 2021
- How a Family's Persistence Led to Their Son's Successful Sickle Cell TreatmentWith the Help of My Special Aflac Duck EBONY - EBONY - September 8th, 2021
- Leukemia Awareness Month: Changing the Future of AML through Precision Medicine - Targeted Oncology - September 8th, 2021
- Third Line Therapies in R/R FL - Cancer Network - September 8th, 2021
- BMS opts-in on Evotec's neurodegenerative medicine - PharmaTimes - September 7th, 2021
- New Cancer Treatments May Be on The Horizon Thanks to Success in mRNA Vaccine Trial - Good News Network - September 7th, 2021
- Billionaires Have Reportedly Invested In A BioTech Company Aiming To Reverse Aging - IFLScience - September 7th, 2021
- Human Mini-Lungs Grown in Lab Dishes are Closest Yet to Real Thing - UC San Diego Health - September 1st, 2021
- Targeting and inhibiting a protein could provide more effective treatment for brain cancer - News-Medical.Net - September 1st, 2021
- Could gene therapies be used to cure more people with HIV? - aidsmap - September 1st, 2021
- BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem Program - Yahoo Finance - September 1st, 2021
- Future Therapeutic Options for Diffuse Large B-Cell Lymphoma - Targeted Oncology - September 1st, 2021
- COVID-19 Causes Severe Disease, Disrupted Treatment in Children with Cancer - Pharmacy Times - September 1st, 2021
- Blood cancer and its impact on female fertility - Lexology - September 1st, 2021
- New gene therapies may soon treat dozens of rare diseases, but million-dollar price tags will put them out of reach for many - The Conversation US - September 1st, 2021
- Global Cryopreservation Equipment Market Report 2021-2028 - Growing Acceptance for Regenerative Medicine & Increasing Needs of Biobanking... - August 30th, 2021
- Bengaluru boy with rare disease meets his German stem cell donor - The Hans India - August 30th, 2021
- Novartis falls behind rivals in race to bring CAR-T to early lymphoma - BioPharma Dive - August 30th, 2021
- Mike Tysons weird stem cell treatment has helped transform incredible body at 55 - Daily Star - August 28th, 2021
- University of Miami Researchers Enter Phase 3 of Stem Cell Clinical Trial in Treating COVID-19 Acute Respiratory Distress Syndrome - Newswise - August 28th, 2021
- Incyte and MorphoSys Announce the European Commission Approval of Minjuvi (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults... - August 28th, 2021
- College of Medicine University of Central Florida Research Wounds Heal Faster with New Treatment: Military Medicine Discovery - PRNewswire - August 28th, 2021
- Lab-grown minibrains with eyes may advance personalized drug testing, researchers say - Mahoning Matters - August 28th, 2021
- Off-the-Shelf NK Cell Products FT596 and FT516 Show Early Promise in B-cell Lymphoma - OncLive - August 28th, 2021
- BioMarin stands tall with first approved drug for rare disease that causes dwarfism - MedCity News - August 28th, 2021
- What to know about the third COVID-19 shot in Gainesville, Alachua County - Gainesville Sun - August 28th, 2021
- Department of Public Health Offering Third Dose COVID-19 Vaccines to Eligible Individuals | Monroe County, NY - monroecounty.gov - August 28th, 2021
- Cell Culture Protein Surface Coating Market | Know the Diverse Growth Parameters Influencing the Market - BioSpace - August 23rd, 2021
- County providing COVID-19 third dose booster to immunocompromised - City of Fort Worth - August 23rd, 2021
- Outcomes For MCL Patients and Impact of Relapse Timing After Transplant on OS - Targeted Oncology - August 23rd, 2021
- SGMC Offering COVID-19 Third Dose to Immunocompromised People - sgmc.org - August 23rd, 2021